ARCHX
Price
$17.26
Change
+$0.06 (+0.35%)
Updated
Apr 2 closing price
Net Assets
50.72M
CLBCX
Price
$34.35
Change
+$0.09 (+0.26%)
Updated
Apr 2 closing price
Net Assets
233.54B
Ad is loading...

ARCHX vs CLBCX

Header iconARCHX vs CLBCX Comparison
Open Charts ARCHX vs CLBCXBanner chart's image
Archer Balanced
Price$17.26
Change+$0.06 (+0.35%)
VolumeN/A
Net Assets50.72M
American Funds American Balanced 529C
Price$34.35
Change+$0.09 (+0.26%)
VolumeN/A
Net Assets233.54B
ARCHX vs CLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARCHX vs. CLBCX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCHX is a Buy and CLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 234B vs. ARCHX (50.7M). ARCHX pays higher dividends than CLBCX: ARCHX (1.32) vs CLBCX (1.22). ARCHX was incepted earlier than CLBCX: ARCHX (20 years) vs CLBCX (23 years). CLBCX (1.37) and ARCHX (1.31) have similar cost to investors . CLBCX is a more actively managed with annual turnover of: 171.00 vs. ARCHX (11.69). CLBCX has a lower initial minimum investment than ARCHX: CLBCX (250) vs ARCHX (2500). CLBCX annual gain was more profitable for investors over the last year : 2.68 vs. ARCHX (1.03). ARCHX return over 5 years is better than : 58.46 vs. CLBCX (44.86).
ARCHXCLBCXARCHX / CLBCX
Total Expense Ratio1.211.3788%
Annual Report Gross Expense Ratio1.311.3796%
Fund Existence20 years23 years-
Gain YTD-1.661-0.0523,207%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets50.7M234B0%
Annual Yield % from dividends1.321.22108%
Returns for 1 year1.032.6838%
Returns for 3 years10.1910.7695%
Returns for 5 years58.4644.86130%
Returns for 10 years66.3052.25127%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIUCX15.18N/A
N/A
JPMorgan Developed International Value C
MSSMX9.37N/A
N/A
Morgan Stanley Inst Inception A
QUASX54.41N/A
N/A
AB Small Cap Growth A
JUEPX23.18N/A
N/A
JPMorgan US Equity R3
ISFIX16.34N/A
N/A
VY® Columbia Contrarian Core I